Keros Therapeutics (KROS) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Keros Therapeutics (KROS) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.38 Bn | 192.39 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 180.22 Bn | 177.04 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.42 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.97 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.49 Bn | 55.30 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.90 Bn | 48.76 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.11 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn | -0.40 |
| 10 | Keros Therapeutics | 219.78 Mn | -37.82 Mn | - | -1.45 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.45 |
| Dec 31, 2025 | -0.62 |
| Sep 30, 2025 | -0.18 |
| Jun 30, 2025 | -0.76 |
| Mar 31, 2025 | 3.62 |
| Dec 31, 2024 | -1.23 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | -1.25 |
| Mar 31, 2024 | -1.21 |
| Dec 31, 2023 | -1.37 |
| Sep 30, 2023 | -1.33 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -1.26 |
| Dec 31, 2022 | -1.18 |
| Sep 30, 2022 | -0.92 |
| Jun 30, 2022 | -1.13 |
| Mar 31, 2022 | -1.01 |
| Dec 31, 2021 | -0.30 |
| Sep 30, 2021 | -0.87 |
| Jun 30, 2021 | -0.67 |